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Topiramate is an antiepileptic medicine that has been used adjunctively in the treatment of refractory
seizures in Japan since 2007. Topiramate has been shown to inhibit speciﬁc carbonic anhydrase activity in
the kidney and may induce a distal type of renal tubular acidosis. Case 1 : A 22-year-old male was referred
to our hospital after complaining of left ﬂank pain. He developed a seizure disorder and had been using
topiramate for 4 months. Drip infusion pyelography showed a left ureteral stone. Case 2 : A 7-year-old
boy presented with gross hematuria. He developed West syndrome and had been using topiramate for 6
months. A computed tomographic scan showed a right kidney stone.
(Hinyokika Kiyo 57 : 125-128, 2011)

















あった．2008年 4月より TPM 25 mg/day が開始され，
発作は消失した．2009年 8月，左側腹部痛を認め近医
受診．尿管結石の疑いで紹介受診された．





Fig. 1. KUB showed a left ureteral stone.







患者 2 : 7歳，男児
主訴 : 肉眼的血尿
既往歴 : West 症候群











TPM [(−) -2, 3 : 4, 5-Di-Ο -isopropylidene-β -D-
fructopyranose sulfamate] は分子式 C12H21NO8S，分子




Fig. 2. CT scan showed a right renal stone.
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Fig. 3. Molecular structure of topiramate.
Table 1. Pharmacologic actions of topiramate
トピラマートの薬力学的特性





















る (Table 1）． この中で結石生成に寄与するのが炭酸
脱水酵素アイソザイムⅡおよびⅣの阻害作用である．














た 2症例は当科受診前の TPM 投与中に検尿，尿化学
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Table 2. Incidence of urolithiasis treated with topiramate
Author Year Type of study Number of patients Mean age (years) Treatment duration (months) Prevalence (％)
Wasserstein, et al. 1995 Retrospective 1,074 1.50％
Sachdeo, et al. 1997 Prospective 48 34.6 4.17％
Abou-Khalil, et al. 2000 Prospective 292 33 13.7 1.00％
Stephen, et al. 2000 Prospective 170 46.5 6 1.80％
Reife, et al. 2000 Prospective 527 34 1.50％
Coppola, et al. 2002 Prospective 45 15.9 15.8 4.50％
Sarah, et al. 2003 Retrospective 40 7.50％
Bootsma, et al. 2004 Retrospective 470 34.9 13.8 1.10％
























































1) Goyal M, Grossberg RI, O’ Riordan MA, et al. :
Urolithiasis with topiramate in nonambulatory child-
ren and young adults. Pediatr Neurol 40 : 289-294,
2009
2) Ramsay L, Michael E, Dennis H, et al. : Topiramate-
induced nephrolithiasis. J Endourol 16 : 229-231,
2002
3) Wasserstein AG, Ihor R, Reife R, et al. : Nephroli-
thiasis during treatment with topiramate. Epilepsia
36 : 153, 1995
4) Sachdeo RC, Reife RA, Lim P, et al. : Topiramate
monotherapy for partial onset seizures. Epilepsia 38 :
294-300, 1997
5) Abou-Khalil B : Topiramate in the long-term manage-
ment of refractory epilepsy. Epilepsia 41 : 72-76,
2000
6) Stephen L, Sills G and Brodie M : Topiramate in
refractory epilepsy : a prospective observational study.
Epilepsia 41 : 977-980, 2000
福本，ほか : トピラマート・結石 127
7) Reife R, Pledger G and Wu S : Topiramate as add-on
therapy : pooled analysis of randomized controlled
trials in adults. Epilepsia 41 : 66-71, 2000
8) Coppola G, Caliendo G, Veggiotti P, et al. : Topira-
mate as add-on drug in children, adolescents and
young adults with Lennox-Gastaut syndrome : an
Italian multicentric study. Epilepsy Res 51 : 147-
153, 2002
9) Sarah M, Anthony H, Gregory L, et al. : Nephroli-
thiasis and nephrocalcinosis in children taking topira-
mate for seizures. Epilepsia 44 : 90, 2003
10) Bootsma H, Coolen F, Aldenkamp A, et al. : Topira-
mate in clinical practice : long-term experience in
patients with refractory epilepsy referred to a tertiary
epilepsy center. Epilepsy Behav 5 : 380-387, 2004
11) Kelly L, Stephen E, John D, et al. : Refractory
hypokalemia : a case of toiramate-induced renal
tubular acidosis. NKF Spring Clinical Meetings
Abstracts 144 : A63, 2008
12) Garris S and Oles K : Impact of topiramate on serum
bicarbonate concentrations in adults. Ann Pharma-
cother 39 : 424-426, 2005
13) 武本征人 : 炭酸脱水酵素阻害剤によって誘発され
る尿路結石の予防に関する臨床的研究．日泌尿会
誌 69 : 968-987，1978
(Accepted on November 14, 2010)
Received on July 5, 2010
泌尿紀要 57巻 3号 2011年128
